Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.
J Clin Oncol. 2006 Jan 20;24(3):394-400. doi: 10.1200/JCO.2005.03.0106.
J Clin Oncol. 2006.
PMID: 16421419
Clinical Trial.
FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study.
Chibaudel B, Tournigand C, Artru P, André T, Cervantes A, Figer A, Lledo G, Flesch M, Buyse M, Mineur L, Carola E, Rivera F, Perez-Staub N, Louvet C, de Gramont A.
Chibaudel B, et al. Among authors: perez staub n.
Ann Oncol. 2009 Aug;20(8):1383-6. doi: 10.1093/annonc/mdp012. Epub 2009 May 22.
Ann Oncol. 2009.
PMID: 19465426
Free article.
Clinical Trial.
Item in Clipboard
Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients.
Maindrault-Goebel F, André T, Tournigand C, Louvet C, Perez-Staub N, Zeghib N, De Gramont A.
Maindrault-Goebel F, et al. Among authors: perez staub n.
Eur J Cancer. 2005 Oct;41(15):2262-7. doi: 10.1016/j.ejca.2005.06.021. Epub 2005 Sep 9.
Eur J Cancer. 2005.
PMID: 16154353
Item in Clipboard
Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer.
de Gramont A, Buyse M, Abrahantes JC, Burzykowski T, Quinaux E, Cervantes A, Figer A, Lledo G, Flesch M, Mineur L, Carola E, Etienne PL, Rivera F, Chirivella I, Perez-Staub N, Louvet C, André T, Tabah-Fisch I, Tournigand C.
de Gramont A, et al. Among authors: perez staub n.
J Clin Oncol. 2007 Aug 1;25(22):3224-9. doi: 10.1200/JCO.2006.10.4380.
J Clin Oncol. 2007.
PMID: 17664470
Clinical Trial.
Item in Clipboard
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
Figer A, Perez-Staub N, Carola E, Tournigand C, Lledo G, Flesch M, Barcelo R, Cervantes A, André T, Colin P, Louvet C, de Gramont A.
Figer A, et al. Among authors: perez staub n.
Cancer. 2007 Dec 15;110(12):2666-71. doi: 10.1002/cncr.23091.
Cancer. 2007.
PMID: 17963264
Free article.
Clinical Trial.
Item in Clipboard
Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study.
Diouf M, Chibaudel B, Filleron T, Tournigand C, Hug de Larauze M, Garcia-Larnicol ML, Dumont S, Louvet C, Perez-Staub N, Hadengue A, de Gramont A, Bonnetain F.
Diouf M, et al. Among authors: perez staub n.
Health Qual Life Outcomes. 2014 May 13;12:69. doi: 10.1186/1477-7525-12-69.
Health Qual Life Outcomes. 2014.
PMID: 24886671
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite